|
GAB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.107600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.335200E-01 |
| Normal-vs-Stage2 |
6.822600E-01 |
| Normal-vs-Stage3 |
3.720600E-01 |
| Normal-vs-Stage4 |
8.613600E-02 |
| Stage1-vs-Stage2 |
4.502000E-01 |
| Stage1-vs-Stage3 |
6.640000E-01 |
| Stage1-vs-Stage4 |
2.199200E-01 |
| Stage2-vs-Stage3 |
3.388400E-01 |
| Stage2-vs-Stage4 |
1.427210E-01 |
| Stage3-vs-Stage4 |
3.216800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.564800E-01 |
| Normal-vs-AfricanAmerican |
9.449800E-01 |
| Normal-vs-Asian |
2.815800E-02 |
| Caucasian-vs-AfricanAmerican |
5.110800E-01 |
| Caucasian-vs-Asian |
3.041400E-01 |
| AfricanAmerican-vs-Asian |
1.574430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.646440E-01 |
| Normal-vs-Female |
4.605800E-01 |
| Male-vs-Female |
1.072970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.422600E-01 |
| Normal-vs-Extreme_Weight |
2.221000E-01 |
| Normal-vs-Obese |
7.810000E-01 |
| Normal-vs-Extreme_Obese |
2.699700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.852200E-01 |
| Normal_Weight-vs-Obese |
2.268200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.134400E-01 |
| Extreme_Weight-vs-Obese |
2.083400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.850400E-01 |
| Obese-vs-Extreme_Obese |
2.824500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.386800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.644400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.584800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.770400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.825400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.479800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.400300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.306000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.056230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.449000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.436500E-02 |
| Normal-VS-Type2 PRCC |
5.641400E-01 |
| Normal-VS-KIRP CIMP |
1.096390E-01 |
| Normal-VS-Unclassified PRCC |
2.065000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.621200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.049900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.866260E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.498100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.208200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.538400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.562000E-01 |
| Normal-vs-N1 |
9.880200E-01 |
| Normal-vs-N2 |
4.480800E-01 |
| N0-vs-N1 |
4.707200E-01 |
| N0-vs-N2 |
3.868600E-01 |
| N1-vs-N2 |
6.963400E-01 |
|
|
